Charming Medical Limited Class A Ordinary Shares

NASDAQ:MCTA

Medical - Care Facilities

Healthcare
$29.36 +0.00%

+$0.00 today

Market cap
$445.55M
Beta
0.00
P/E (TTM)
414.6
EPS (TTM)
$0.07
52W Low $4.30High $31.70

Volume 0.00M

Average 0.87M

MCTA Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

Charming Medical Limited Class A Ordinary SharesNASDAQ: MCTA

Accounts Payables · FY2024 · year ended Mar 2025

Accounts payables turns negative

FY2024 accounts payables was -$204.69K, compared with $210.28K a year earlier.

Context

  • Accounts payables amounted to 3.3% of revenue in FY2024, down 0.2 pp from a year earlier.
  • Accounts payables increased in 1 of the last 2 fiscal years.
  • FY2024 was the lowest annual figure in the 3 fiscal years shown.

Sources:Cash FlowText generated from reported figures; not investment advice.

Last fiscal yearMar 2025
-$204.69K-197.3% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year-197.3%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2024
(204.69K) USD
Year-over-year change
-197.3%

Accounts Payables vs competitors

How MCTA compares with its peers on the latest reported figures

  • MCTA's FY2024 accounts payables of $204.69K is the 7th largest of the 10 companies compared; the peer median is $0.
  • Its year-over-year change of -197.3% is the 8th highest of 9, against a peer median of -47.4%.
  • Accounts payables amounts to 3.3% of revenue for MCTA, versus a peer median of 0.4%.
MCTA Competitors Peer median
Accounts Payables for MCTA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TOIThe Oncology Institute, Inc.LTM Mar 2026$19.19M +142.5%—3.5%
NAKANakamoto Inc.LTM Mar 2026$8.24M -11230.1%—210.1%
ANNXAnnexon, Inc.LTM Mar 2026$6.67M +3.7%——
DCTHDelcath Systems, Inc.LTM Mar 2026$5.42M +544.5%+38.4%6.0%
CCRNCross Country Healthcare, Inc.LTM Mar 2026$3.45M -134.0%—0.3%
SLPSimulations Plus, Inc.LTM Feb 2026$403K +352.8%-6.6%0.5%
MCTACharming Medical Limited Class A Ordinary SharesFY2024$204.69K -197.3%—3.3%
TCMDTactile Systems Technology, Inc.LTM Mar 2026$26K -98.5%—0.0%
RXSTRxSight, Inc.LTM Mar 2026$22K -101.1%-0.4%0.0%
AGLAgilon Health, Inc.LTM Mar 2026$0 ——0.0%
Peer median (excluding MCTA) $0-47.4%-0.4%0.4%

Competitors are the stored peer set for MCTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
Net Income(335.61K)821.74K1.2M
Depreciation & Amortization211.08K391.7K263.45K
Deferred Income Tax062.48K134.87K
Stock-Based Compensation000
Change in Working Capital2.5M(943.05K)(1.16M)
Accounts Receivables(154.02K)(164.98K)(44.29K)
Inventory(55.87K)38.18K1.35K
Accounts Payables180.4K210.28K(204.69K)
Other Working Capital2.53M(1.03M)(913.02K)
Other Non-Cash Items60.9K(37.45K)(10.89K)
Operating Cash Flow2.43M295.43K425.89K
Capital Expenditures(606.19K)(210.6K)(287.53K)
Acquisitions (Net)000
Purchases of Investments00(1.94M)
Sales of Investments000
Other Investing Activities000
Investing Cash Flow(606.19K)(210.6K)(2.23M)
Debt Repayment(177.92K)(115.85K)48.93K
Common Stock Issued000
Common Stock Repurchased000
Dividends Paid000
Other Financing Activities(1.25M)216K472.37K
Financing Cash Flow(1.43M)100.15K521.3K
Effect of Forex Changes5.66K(10.51K)(4.62K)
Net Change in Cash402.99K174.46K(1.29M)
Free Cash Flow1.83M84.83K138.36K

Charming Medical Limited Class A Ordinary Shares

NASDAQ:MCTA

Intrinsic Alpha fair value

Locked

Current Price

$29.36

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.